Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Journal of Gastroenterology
Published in: Journal of Gastroenterology 4/1998

01-07-1998

Differences in antigenic sites, recognized by anti-liver-kidney microsome-1 (LKM-1) autoantibody, between HCV-positive and HCV-negative sera in Japanese patients

Authors: Hiroshi Miyakawa, Hiroshi Matsushima, Yoichi Narita, Raleigh W. Hankins, Eriko Kitazawa, Hirotoshi Fujikawa, Kentaro Kikuchi, Masanao Matsushita, Kazuhiro Abe, Naomi Kawaguchi, Toshio Morizane, Makoto Kako

Published in: Journal of Gastroenterology | Issue 4/1998

Login to get access
Metadata
Title
Differences in antigenic sites, recognized by anti-liver-kidney microsome-1 (LKM-1) autoantibody, between HCV-positive and HCV-negative sera in Japanese patients
Authors
Hiroshi Miyakawa
Hiroshi Matsushima
Yoichi Narita
Raleigh W. Hankins
Eriko Kitazawa
Hirotoshi Fujikawa
Kentaro Kikuchi
Masanao Matsushita
Kazuhiro Abe
Naomi Kawaguchi
Toshio Morizane
Makoto Kako
Publication date
01-07-1998
Publisher
Springer-Verlag
Published in
Journal of Gastroenterology / Issue 4/1998
Print ISSN: 0944-1174
Electronic ISSN: 1435-5922
DOI
https://doi.org/10.1007/s005350050127

Other articles of this Issue 4/1998

Journal of Gastroenterology 4/1998 Go to the issue

OriginalPaper

Rectal mucosal hemodynamics, evaluated by reflectance spectrophotometry, in patients with chronic hepatitis

OriginalPaper

Natural course of portal hemodynamics in patients with chronic liver diseases, evaluated by per-rectal portal scintigraphy with Tc-99m pertechnetate

Case report

Combined hepatocellular and cholangiocellular carcinoma in a non-cirrhotic liver

Case report

Steroid-refractory severe ulcerative colitis responding to cyclosporine and long-term follow-up

Case report

Endoscopic injection sclerotherapy with n-butyl-2-cyanoacrylate for ruptured duodenal varices

OriginalPaper

Influence of biliary obstruction on neutrophil chemotaxis
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits